Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin and Attention Control in Healthy Males
NCT04493554Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jul 2020
- Primary completion
- Nov 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of vasopressin, sponsored by University of Electronic Science and Technology of China. Primary endpoints: Saccade/Antisaccade Latency and Saccade/Antisaccade Error Rate. Started Jul 2020; status: completed.
02
Drugs
vasopressin
Beyond the preview
Go deeper on NCT04493554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493554.